Abstract
Background
Bilateral vestibular schwannomas (VS) are pathognomonic of Neurofibromatosis type 2 (NF2), but the diagnostic criteria also include unilateral vestibular schwannomas (UVS) in combination with multiple meningiomas (MM) and other schwannomas, as well as MM without VS.
Objective
To investigate the diagnostic value of these criteria and establish the presence of other genetic conditions in patients presenting in this manner.
Methods
The (BLINDED FOR REVIEW) NF2 database was accessed to obtain information on patients presenting with a UVS and MM or ≥2 non-intradermal schwannomas (NIDS). We gathered data on patients diagnosed with NF2 due to MM without VS, and on patients presenting with MM without meeting NF2 criteria. Analysis was performed for pathogenic variants (PV) in NF2, SMARCE1, SMARCB1 and LZTR1.
Results
131/131 patients presenting with a UVS and MM had a non-refuted diagnosis of NF2 after molecular studies, in comparison with 85/96 patients presenting with UVS and ≥2 NIDS (p=<0.00001). 50% presenting with a UVS and ≥2 NIDS with NF2 developed bilateral VS, compared to only 26% of those who presented with a UVS and MM (p=0.0046). 11/152 patients presenting with MM without fulfilling NF2 criteria were found to have a PV in SMARCE1, and 7/152 were confirmed to have mosaic NF2.
Conclusion
Patients presenting with UVS and MM are significantly more likely to have a non-refuted diagnosis of NF2 than patients presenting with UVS and ≥2 NIDS, but significantly less likely to develop bilateral VS. 7% of those presenting with MM without meeting NF2 criteria had PV in SMARCE1, and 5% had mosaic NF2.
Bilateral vestibular schwannomas (VS) are pathognomonic of Neurofibromatosis type 2 (NF2), but the diagnostic criteria also include unilateral vestibular schwannomas (UVS) in combination with multiple meningiomas (MM) and other schwannomas, as well as MM without VS.
Objective
To investigate the diagnostic value of these criteria and establish the presence of other genetic conditions in patients presenting in this manner.
Methods
The (BLINDED FOR REVIEW) NF2 database was accessed to obtain information on patients presenting with a UVS and MM or ≥2 non-intradermal schwannomas (NIDS). We gathered data on patients diagnosed with NF2 due to MM without VS, and on patients presenting with MM without meeting NF2 criteria. Analysis was performed for pathogenic variants (PV) in NF2, SMARCE1, SMARCB1 and LZTR1.
Results
131/131 patients presenting with a UVS and MM had a non-refuted diagnosis of NF2 after molecular studies, in comparison with 85/96 patients presenting with UVS and ≥2 NIDS (p=<0.00001). 50% presenting with a UVS and ≥2 NIDS with NF2 developed bilateral VS, compared to only 26% of those who presented with a UVS and MM (p=0.0046). 11/152 patients presenting with MM without fulfilling NF2 criteria were found to have a PV in SMARCE1, and 7/152 were confirmed to have mosaic NF2.
Conclusion
Patients presenting with UVS and MM are significantly more likely to have a non-refuted diagnosis of NF2 than patients presenting with UVS and ≥2 NIDS, but significantly less likely to develop bilateral VS. 7% of those presenting with MM without meeting NF2 criteria had PV in SMARCE1, and 5% had mosaic NF2.
| Original language | English |
|---|---|
| Journal | Neurosurgery |
| Early online date | 30 Mar 2022 |
| DOIs | |
| Publication status | Published - 30 Mar 2022 |
